The Vanguard Group 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 1:54 pm Sale | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,257,493 10.040% | -696,740 (-7.00%) | Filing |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,954,233 11.120% | 642,472 (+6.90%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,311,761 11.490% | 162,240 (+1.77%) | Filing |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 9,149,521 11.460% | 852,657 (+10.28%) | Filing |
| 2021-02-10 11:28 am Sale | 2020-12-31 | 13G | Myriad Genetics, Inc. MYGN | The Vanguard Group | 8,296,864 11.030% | -23,710 (-0.28%) | Filing |